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Abstract  
 
BACKGROUND: The perioperative period may be associated with a marked neurohumoral 
stress response, significant fluid losses and varied fluid replacement regimes. Acute 
changes in serum sodium concentration are therefore common, but predictors and 
outcomes of these changes have not been investigated in a large surgical population. 
METHODS: We carried out a retrospective cohort analysis of 27,068 in-patient non-
cardiac surgical procedures in a tertiary teaching hospital setting. Data on preoperative 
conditions, perioperative events, hospital length of stay and mortality were collected, along 
with preoperative and postoperative serum sodium measurements up to seven days after 
surgery. Logistic regression was used to investigate the association between sodium 
changes and mortality, and to identify clinical characteristics associated with a deviation 
from baseline sodium greater than 5 mmol/l. 
RESULTS: Changes in sodium concentration > 5mmol/l were associated with increased 
mortality risk (adjusted OR 1.49 for a decrease, 3.02 for an increase). Factors 
independently associated with a perioperative decrease in serum sodium concentration >5 
mmol/l included age >60, diabetes mellitus and use of patient-controlled opioid analgesia.  
Factors associated with a similar increase were preoperative oxygen dependency, 
mechanical ventilation, central nervous system depression, non-elective surgery and major 
operative hemorrhage.  
CONCLUSIONS:  Maximum deviation from preoperative serum sodium value is 
associated with increased hospital mortality in patients undergoing in-patient non-cardiac 
surgery.  Specific preoperative and perioperative factors are associated with significant 
serum sodium changes.  
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Introduction 
 
Disorders of plasma sodium concentration are common in hospitalized patients and are 
associated with increased hospital stay, resource utilization and mortality. Surgical patients 
may be particularly vulnerable, since the perioperative period is often characterized by a 
vigorous neurohumoral stress response, significant fluid losses and widely varying fluid 
replacement regimes.  Previous studies have reported hospital outcomes associated with 
dysnatraemias present on admission, in specific medical or surgical subspecialties, in 
intensive care, or in mixed medical-surgical populations without reference to the 
perioperative period.1-7 Only two studies have focused exclusively on perioperative 
patients. Leung et al reported increased mortality in patients with preoperative 
hyponatraemia using data from the American College of Surgeons National Surgical 
Quality Improvement Program (ACS NSQIP),6 and McCausland et al described similar 
outcomes in dysnatraemic patients after orthopaedic surgery.7  No previous study has 
investigated perioperative sodium changes.  
 
While small changes are commonplace and may typically reflect measurement artifact or 
diurnal variation, 8-10 large changes are often associated with endocrine or iatrogenic 
factors. These can be harmful in themselves, by inducing osmotic disequilibrium and 
cerebral dysfunction 11 12, or may reflect an underlying impairment of sodium and water 
homeostasis that predicts adverse outcomes independently of prevention or treatment. 
However, both predictors and outcomes of marked changes remain poorly characterized, 
and the possibility remains that intervention to minimize sodium fluctuations may be 
beneficial. Hence we investigated a large cohort of patients undergoing intermediate and 
major in-patient surgery to identify clinical correlates of moderate-to-severe sodium 
changes, and to quantify any associated increase in mortality.  We speculated that 
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knowledge of these factors, and closer attention to electrolyte monitoring and fluid therapy 
in patients at increased risk, might attenuate any associated increase in mortality.  
  
  
5 
Methods 
 
With local research ethics committee approval, we extracted anonymised electronic 
records of 31,206 in-patient surgical procedures lasting more than one hour at Cambridge 
University Hospitals between 1 January 1996 and 31 December 2005. This encompassed 
all specialties with the exception of cardiothoracic surgery.  Hospital length of stay and 
mortality were obtained from the hospital’s administrative database, while information on 
co-morbidities, important preoperative conditions and perioperative events was available 
from a perioperative audit database, as recorded during each procedure by the attending 
anaesthetist.  
 
A laboratory database provided measurements of serum sodium concentration, including 
the latest preoperative value as baseline (no earlier than 14 days preoperatively), and all 
values in the first 7 days after surgery. The highest and lowest sodium values in the first 7 
postoperative days were then compared to baseline to define the following mutually 
exclusive categories for analysis: no change greater than 5 mmol/l; decrease greater than 
5 mmol/l; increase greater than 5 mmol/l; both increase and decrease greater than 5 
mmol/l.  
 
Obstetric and paediatric patients (under age 13) were excluded from the study population, 
as were those missing either preoperative or postoperative sodium measurements, and 
those without complete data on preoperative conditions and perioperative events. Only the 
first surgical procedure carried out during an admission was studied.  
 
The above exclusions ensured that we studied a high risk cohort, since all had surgery 
involving more than one hour of operating time, and all had both preoperative and 
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postoperative sodium measurements. Preoperative measurement in particular would 
suggest co-morbidity, major surgery, or both. We were unable to collect data on 
perioperative fluids from the records obtained. 
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Statistical analysis  
 
Summary statistics were computed for baseline characteristics and outcomes of the 
cohort.  Hospital admissions were fitted in a multivariate logistic regression model to 
investigate the association between maximum change in sodium concentration and 
hospital mortality.   The model was adjusted for co-morbidities and other relevant 
confounders, as well as for possible correlation between admissions of the same patient.  
Odds ratios were adjusted using the floating absolute risk method to allow comparison 
between potential confounders, rather than only comparison of each to its absence.13  
Multivariate logistic regression was also used to identify co-morbidities and conditions 
associated with large changes in sodium (>5 mmol/l). 
 
All models were adjusted by the number of postoperative sodium measurements, to 
minimise bias related to clinical acuity, and by calendar year to allow for differences in 
clinical practice over time.  Forward selection procedures were used to obtain the most 
parsimonious model using likelihood ratio tests. All analyses were performed using Stata 
(version 10.1) and significance was set at 5%. 
 
Results 
 
Study population  
 
Complete data were available for 16,216 admissions (14,942 patients).  Exclusions are 
shown in Online Supplementary Figure 1, the largest number resulting from missing values 
for physician-entered preoperative and perioperative variables. Baseline characteristics 
and outcomes are shown in Table 1. In 86.2% of admissions, at least one significant 
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preoperative condition was present; in 45.8%, ASA Physical Status was assessed as 3 or 
higher. The most prevalent co-morbidities included hypertension (29.4%), malignancy 
(16.1%), ischemic heart disease (15.3%) and obesity (11.9%). There were 632 hospital 
deaths, corresponding to a mortality of 3.9%. 
 
Sodium changes and hospital mortality 
 
Associations between perioperative changes in sodium concentration and hospital 
mortality are shown in Figure 1.  A deviation from the preoperative value of greater than 5 
mmol/l in either direction was associated with a higher risk of death than patients with 
smaller changes. This was strongest with increases, which carried three times the risk 
(adjusted odds ratio (OR) 3.02; 95% CI, 2.52-3.62) of those with small or no change.  Falls 
in sodium increased mortality by about 50% (OR, 1.49; 95% CI, 1.21-1.83).  When 
preoperative sodium concentration was normal the relationships were more pronounced, 
with odds ratios of 3.49 and 1.62 for increases and decreases, respectively.  
 
Clinical correlates of large sodium changes  
 
Figures 2 and 3 show the results of multivariate logistic regression investigating clinical 
correlates of large perioperative decreases and increases, respectively.  Figure 2 shows 
that those more likely to have a large decrease in sodium concentration were older (>60 
years, OR 1.34), and had procedures of longer duration (OR 1.30). Those with diabetes 
(OR 1.30) or liver disease (undergoing transplant, OR 1.74), who were mechanically 
ventilated (OR 1.41) or receiving oxygen (OR 1.55), and who used patient-controlled 
analgesia in the postoperative period (OR 1.21), were all more likely to have a large 
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decrease in sodium than those who were not. Major urological and renal procedures were 
also associated with this risk (OR 1.35), compared to a reference group comprising all in-
patient laparoscopic operations.  Obesity appeared to be protective against large 
decreases (OR .80). 
 
Figure 3 shows the adjusted clinical correlates of large sodium increases. These also 
included longer operations (OR 2.31), and preoperative ventilation (OR 1.65) or oxygen 
(OR 2.19).  Non-elective surgery (OR 1.97) was predictive, as were the preoperative 
presence of a neurological (OR 1.33) or endocrine condition (OR 1.27), or central nervous 
system depression (OR 1.97). Major haemorrhage (> ½ blood volume) during surgery was 
also powerfully associated with a large sodium increase (OR 2.77). Again, obesity 
appeared to be protective (OR .77).  
 
Discussion 
 
Sodium homeostasis is achieved by the complex interplay of the renal renin-angiotensin-
aldosterone system, sympathetic neural and catecholamine activity, secretion of 
vasopressin from the neurohypophysis, and release of natriuretic peptides from 
myocardium.12  Both osmoreceptors and baroreceptors regulate vasopressin secretion, 
and the effects of vasopressin on the renal excretion of water are influenced by genetic 
polymorphisms.14 15 Aquaporins and ATPases further regulate cell membrane water and 
sodium flux in the face of changes in extracellular ion concentration. 16 17 In health, thirst 
ensures adequate intake while renal mechanisms closely control losses. In the 
perioperative setting, however, many of these systems are affected by inflammation and 
neuroendocrine responses to surgical stress, and the adaptive capacity of the global 
homeostatic response may be impaired.18 19 Little is known about the relative importance 
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of constitutional versus iatrogenic factors in this context, but available data suggest that 
both are relevant and that treatment should be carefully individualised. 12 20-22 
 
Pre-admission and hospital acquired dysnatraemias are known to be associated with 
increased resource utilization and mortality in mixed medical-surgical and intensive care 
populations, 1-5 11 23-25 and more recently have been linked to mortality in two large cohorts 
of post-surgical patients.6 7 Sodium variability per se also predicted increased mortality in 
patients admitted to a surgical ICU.26 This study has demonstrated similar outcomes in a 
large population undergoing in-patient surgery, and has added new data on the predictors 
and outcomes of perioperative sodium changes.   
 
We have shown that deviations from baseline greater than 5 mmol/l are associated with 
increased hospital mortality, even when preoperative values are normal. We selected the 
threshold of >5 mmol/l deviation from preoperative baseline because lesser changes are 
typical in stable, uncomplicated perioperative patients, and are known to be confounded 
by diurnal variation, blood glucose and protein concentrations, and laboratory 
imprecision.8-10 Also, changes of this magnitude were not found to predict mortality in a 
large study of patients treated in surgical intensive care.26  Although dysnatraemias may 
represent non-causal biomarkers of underlying neuroendocrine or inflammatory disorders, 
and correction may not necessarily provide benefit, clinical experience and published data 
strongly suggest that fluid management does affect outcomes and that dysnatraemia may 
be avoided.27-32 Thus, sodium values may merit closer attention than they currently 
receive. While doses of potassium, glucose and even water are regularly adjusted in 
surgical patients, sodium is delivered at standard concentrations as long as serum values 
are normal. With greater consideration of the last-recorded sodium measurement and of 
easily measured sodium losses in urine and drains, some variability may be prevented, 
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reducing osmotic shifts and associated effects on organ function, and improving 
outcomes.27 
 
In support of this hypothesis, this study has identified some conditions linked to marked 
sodium changes that may be easily remediable. Diabetes mellitus predicted large 
decreases, raising concerns about water excess associated with the widespread, 
protocolised use of 5% glucose with variable-rate intravenous insulin infusion in post-
surgical patients. This regime was standard therapy at the time of this study and its use 
continues. 10% glucose and concurrent balanced electrolyte solutions given via central 
venous catheter may be safer in this group. Diabetics, along with the elderly, patients on 
patient-controlled opiate analgesia, and those undergoing major urological procedures 
would be appropriately targeted for more frequent serum sodium measurements and more 
variable sodium replacement regimes. 
 
Major operative haemorrhage was a powerful independent predictor of an increase in 
sodium concentration, supporting other evidence that the sodium load associated with 
administration of bank blood may be detrimental. This too underscores the potential 
benefits of prevention in high-risk cases, by prophylactic administration of tranexamic acid, 
washing of bank blood using cell salvage equipment to reduced citrate-associated sodium 
loading, or concomitant administration of low-sodium crystalloid. Moreover, the 
prominence in this study of oxygen therapy and mechanical ventilation as predictors of 
large sodium changes in the critical care setting, where closer monitoring and more 
intensive management are easiest to implement, suggests another opportunity for 
beneficial impact. The importance of frequent monitoring of a rising or falling serum 
sodium is clear. 
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The protective effect of obesity in relation to both hypo- and hypernatraemia was an 
unexpected finding. This suggests enhanced osmoregulation rather than fluid regimes 
influenced by weight or a higher prevalence of hyperaldosteronism, both of which would 
protect from only one of these disorders. However, effects of obesity on cytokine profile, 
chronic inflammation and neuroendocrine function, including renal responses to sodium 
intake, are well recognized 33 and some may be beneficial. Indeed, since moderate obesity 
is known to confer a survival advantage in some surgical and critical care settings, a 
positive effect on sodium homeostasis seems possible.  
 
Another important implication of our findings relates to the approach to the dysnatraemic 
patient presenting for surgery, which has received little attention in the literature and 
remains largely arbitrary. Abnormalities of preoperative serum sodium values are common, 
but few cases are investigated and treated before elective surgery. Most cases of mild 
preoperative hyponatraemia appear to be related to long term drug treatments. These 
include thiazide diuretics, angiotensin converting enzyme inhibitors, non-steroidal anti-
inflammatory drugs, selective serotonin re-uptake inhibitors, proton pump inhibitors, 
narcotics and numerous others.34-38 However, we suggest that when a cause is not 
apparent any abnormality found before major elective surgery should be investigated, for 
the following reasons.  First, abnormal serum sodium values may worsen perioperatively if 
the underlying condition is intensified, as may occur in the syndrome of inappropriate 
antidiuresis (SIAD), the most common cause of perioperative hyponatraemia. Second, if 
major fluid replacement is needed, especially transfusion of citrated bank blood, rapid 
changes in serum sodium may lead to dangerous osmotic syndromes, including cerebral 
edema and demyelination.39 40 Lastly, underlying disorders that remain undiagnosed may 
have unpredictable consequences in the perioperative period. These include 
hypovolaemic states (including renal impairment and cerebral salt-wasting syndrome), 
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diverse malignancies, hypothyroidism, hypoadrenalism, diabetes, heart failure, liver 
disease and nephrotic syndrome. Most of these are identifiable with simple screening 
tests, and are treatable.28  
 
A number of features of this study may limit generalisation of our results. Our selection 
criteria isolated a high risk cohort of patients undergoing intermediate and major surgical 
procedures, and interpretation of our results should take this into account. Our data was 
derived from a single center and collected over a 10 year period, so case-mix and 
management trends may have been idiosyncratic and probably varied over time. Most 
importantly, we were unable to collect detailed data on perioperative fluid losses and 
replacement. These parameters may be powerful correlates of serum sodium changes and 
may be the most readily altered by physician intervention.  
 
Variability in the number of postoperative sodium measurements may have influenced 
some of our findings,. since the number of measurements was undoubtedly an indication 
of the severity of co-morbid conditions and of the scale of surgery. However, since 
adjustment for this and for many other indicators of acuity failed to alter the impact of large 
changes, it is likely that any effect was small. 
 
Although a strength of the study was the reliance on attending and resident physicians for 
entry of data on preoperative conditions, the numbers we studied were reduced by the 
failure of many to confirm the absence of chronic co-morbidities on our optically-read 
forms. Since a clear negative response to this question was a condition of inclusion in our 
primary analysis, healthy patients may have been excluded and reduced denominators 
could have exaggerated the incidence and prevalence of sodium conditions. However, by 
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increasing case-mix severity, these omissions may also have enhanced the study’s ability 
to identify relevant clinical predictors.  
 
We were unable to collect data on preoperative volume status, on postoperative symptoms 
related to dysnatraemia, nor on neurological outcomes such as osmotic demyelination 
syndromes, which would have strengthened the predictive value of the analysis greatly. It 
is also arguable that the collection of data on post-discharge outcomes would have 
enhanced our understanding of risk in this cohort, although this has been done by others 
and it is unlikely that our key findings would have been altered.    
 
The absence of routine simultaneous determinations of blood glucose meant that we could 
not adjust for hyperglycemia. This may have affected the rates of both dysnatraemias.23 
However, Waikar, Mount and Curhan showed that adjustment for glucose concentrations 
had a very minor effect on prevalence of hyponatraemia and no effect on associations with 
mortality, so this is unlikely to be important.3 
 
In conclusion, this study has confirmed that perioperative dysnatraemias associated with 
deviations greater than 5 mmol/l from preoperative values, and overall variability of sodium 
measurements, are associated with significantly increased hospital mortality. Specific 
preoperative and perioperative factors are independently predictive of these changes. 
Although the role of perioperative fluid therapy could not be addressed in this study, nor 
any direct causative link between sodium changes and mortality inferred, these findings 
enhance risk evaluation in the surgical patient and raise the possibility that both closer 
monitoring of serum sodium and more careful attention to the volume and content of 
perioperative fluids may be beneficial in high-risk patients. The definitive determination of 
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iatrogenic causes and of the value of prevention will require prospective collection of 
detailed data on fluids and medications, and randomised trials of specific regimes. 
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Table 1. Characteristics and outcomes of cohort (16,216 admissions, 14,942 unique patients) 
Variable Subgroup 
Mean(range) / 
N(%) 
Age  58 (13 to 104) 
Gender Male 7,563 (46.6) 
 Female 8,653 (53.4) 
Type of surgery Elective 11,363 (70.1) 
 Non-elective 4,853 (29.9) 
ASA score 1 2,873 (17.7) 
 2 5,917 (36.5) 
 3 6,041 (37.3) 
 4 1,289 (7.9) 
 5 96 (0.6) 
Preoperative sodium concentration 
(mmol/l) 135-145 14,111 (87.0) 
 125-134 1,502 (9.3) 
 <125 47 (0.3) 
 146-155 550 (3.4) 
 >155 6 (0.0004) 
Preoperative conditions Use of cardiovascular drugs 3,787 (23.4) 
 Oxygen therapy 648 (4.0) 
 Ventilated 479 (3.0) 
 Bedridden > 2 weeks 520 (3.2) 
 CNS depression 662 (4.1) 
Co-morbidities Obesity 1,927 (11.9) 
 Hypertension 4,770 (29.4) 
 Smoking 1,645 (10.1) 
 Asthma 1,148 (7.1) 
 Ischaemic heart disease 2,483 (15.3) 
 Structural heart defect 488 (3.0) 
 Cardiac failure 594 (3.7) 
 Peripheral vascular disease 1,116 (6.9) 
 Cerebrovascular disease 1,073 (6.6) 
 COAD 638 (3.9) 
 Diabetes 1,197 (7.4) 
 
Steroid use >2 months/other 
endocrine 1,387 (8.6) 
 Liver disease (with transplant) 295 (1.8) 
 Liver disease (no transplant) 455 (2.8) 
 Renal disease 1,485 (9.2) 
 Haematological disease 336 (2.1) 
 Seizure disorder 342 (2.1) 
 Other CNS disease 1,564 (9.6) 
 Malignancy 2,604 (16.1) 
 Rheumatoid arthritis 442 (2.7) 
No co-morbidities or significant 
preoperative conditions  2,233 (13.8) 
Hospital outcome Length of postoperative stay* (days) 8 (5-15) 
 Died in hospital 632 (3.9) 
 
COAD=chronic obstructive airways disease, CNS=central nervous system, SD=standard deviation.   *Median 
value (with interquartile range) presented instead of mean.   
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Figure 1. Perioperative sodium changes and hospital mortality 
*Decrease and Increase (>5 mmol/l) categories exclude those who also had >5 mmol/l change in the 
opposite direction. The latter were categorised as “Both decrease and increase >5mmol/l”. Model adjusted 
by age, ASA score, elective/non-elective surgery, co-morbidities, significant preoperative conditions, 
preoperative sodium concentration, number of postoperative sodium measurements, type of operation, 
preoperative length of stay and year of admission. 
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Figure 2. Patient and clinical correlates of sodium decreases >5 mmol/l. 
Model adjusted by all variables presented, as well as by calendar year, preoperative length of stay and 
preoperative sodium concentration.  Operative procedures (using OPCS) were fitted as a single categorical 
variable.  Categories were displayed only if they were statistically significant. 
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Figure 3. Patient and clinical correlates of increases in sodium >5 mmol/l. 
Model adjusted by all variables presented, as well as by calendar year, preoperative length of stay and 
preoperative sodium concentration.  Operative procedures (using OPCS) were fitted as a single categorical 
variable.  Categories were displayed only if they were statistically significant. 
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Supplementary figure 1. Flow diagram showing exclusions from final data set 
 
 
 
 
